Search research articles
Contact Us
Filters
Showing results (121-130 of 170) with videos related to
Page
of 17
Sort By:
BMC Health Services Research
|
March 21, 2021
Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV: perspectives of health care providers participating in phase 3 trials
Andrea Mantsios, Miranda Murray, Tahilin S Karver, et al.
Culture, Health & Sexuality
|
May 22, 2020
"I feel empowered": women's perspectives on and experiences with long-acting injectable antiretroviral therapy in the USA and Spain
Andrea Mantsios, Miranda Murray, Tahilin S Karver, et al.
The Journal of Infectious Diseases
|
February 5, 2009
Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy: final 48-week clinical and virologic outcomes
Timothy J Wilkin, John E McKinnon, A Gregory DiRienzo, et al.
The New England Journal of Medicine
|
May 16, 2008
Class-sparing regimens for initial treatment of HIV-1 infection
Sharon A Riddler, Richard Haubrich, A Gregory DiRienzo, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 17, 2021
A Semimechanistic Model of the Bactericidal Activity of High-Dose Isoniazid against Multidrug-Resistant Tuberculosis: Results from a Randomized Clinical Trial
Kamunkhwala Gausi, Elisa H Ignatius, Xin Sun, et al.
Open Forum Infectious Diseases
|
January 5, 2026
Monocyte Activation in People With HIV and Tuberculosis Coinfection and Effect of Tuberculosis Preventive Therapy: An Analysis of the ACTG A5279/BRIEF TB Trial
Moises A Huaman, Manuel G Feria, Michelle A Kendall, et al.
The Journal of Antimicrobial Chemotherapy
|
June 9, 2022
Pharmacokinetics of standard versus high-dose isoniazid for treatment of multidrug-resistant tuberculosis
Kamunkhwala Gausi, Maxwell Chirehwa, Elisa H Ignatius, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 27, 2021
Resistance to Mycobacterium tuberculosis Infection Among Household Contacts: A Multinational Study
Davit Baliashvili, Neel R Gandhi, Soyeon Kim, et al.
BMC Infectious Diseases
|
February 25, 2021
Drug susceptibility patterns of Mycobacterium tuberculosis from adults with multidrug-resistant tuberculosis and implications for a household contact preventive therapy trial
Anne-Marie Demers, Soyeon Kim, Sara McCallum, et al.
Journal of Viral Hepatitis
|
March 28, 2024
Preferences and feasibility of long-acting technologies for treatment of hepatitis C virus in low- and middle-income countries: A survey of providers and policymakers
Neil Gupta, Susan Swindells, Kimberly K Scarsi, et al.
Page
of 17
Search research articles
Search
Showing results (121-130 of 170) with videos related to
Sort By:
Page
of 17
BMC Health Services Research
|
March 21, 2021
Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV: perspectives of health care providers participating in phase 3 trials
Andrea Mantsios, Miranda Murray, Tahilin S Karver, et al.
Culture, Health & Sexuality
|
May 22, 2020
"I feel empowered": women's perspectives on and experiences with long-acting injectable antiretroviral therapy in the USA and Spain
Andrea Mantsios, Miranda Murray, Tahilin S Karver, et al.
The Journal of Infectious Diseases
|
February 5, 2009
Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy: final 48-week clinical and virologic outcomes
Timothy J Wilkin, John E McKinnon, A Gregory DiRienzo, et al.
The New England Journal of Medicine
|
May 16, 2008
Class-sparing regimens for initial treatment of HIV-1 infection
Sharon A Riddler, Richard Haubrich, A Gregory DiRienzo, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 17, 2021
A Semimechanistic Model of the Bactericidal Activity of High-Dose Isoniazid against Multidrug-Resistant Tuberculosis: Results from a Randomized Clinical Trial
Kamunkhwala Gausi, Elisa H Ignatius, Xin Sun, et al.
Open Forum Infectious Diseases
|
January 5, 2026
Monocyte Activation in People With HIV and Tuberculosis Coinfection and Effect of Tuberculosis Preventive Therapy: An Analysis of the ACTG A5279/BRIEF TB Trial
Moises A Huaman, Manuel G Feria, Michelle A Kendall, et al.
The Journal of Antimicrobial Chemotherapy
|
June 9, 2022
Pharmacokinetics of standard versus high-dose isoniazid for treatment of multidrug-resistant tuberculosis
Kamunkhwala Gausi, Maxwell Chirehwa, Elisa H Ignatius, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 27, 2021
Resistance to Mycobacterium tuberculosis Infection Among Household Contacts: A Multinational Study
Davit Baliashvili, Neel R Gandhi, Soyeon Kim, et al.
BMC Infectious Diseases
|
February 25, 2021
Drug susceptibility patterns of Mycobacterium tuberculosis from adults with multidrug-resistant tuberculosis and implications for a household contact preventive therapy trial
Anne-Marie Demers, Soyeon Kim, Sara McCallum, et al.
Journal of Viral Hepatitis
|
March 28, 2024
Preferences and feasibility of long-acting technologies for treatment of hepatitis C virus in low- and middle-income countries: A survey of providers and policymakers
Neil Gupta, Susan Swindells, Kimberly K Scarsi, et al.
Page
of 17